Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis
In the last years, a growing amount of evidence has been produced regarding the role of
leukocytosis as a risk factor for thrombosis in patients with myeloproliferative neoplasms …
leukocytosis as a risk factor for thrombosis in patients with myeloproliferative neoplasms …
Genetics of myeloproliferative neoplasms
AD Viny, RL Levine - The Cancer Journal, 2014 - journals.lww.com
In the last decade, genomic studies have identified multiple recurrent somatic mutations in
myeloproliferative neoplasms (MPNs). Beginning with the discovery of the JAK2 V617F …
myeloproliferative neoplasms (MPNs). Beginning with the discovery of the JAK2 V617F …
Application of Fourier Transform InfraRed spectroscopy of machine learning with Support Vector Machine and principal components analysis to detect biochemical …
Primary myelofibrosis (PM) is a myeloproliferative neoplasm characterized by stem cell-
derived clonal neoplasms. Several factors are involved in diagnosing PM, including physical …
derived clonal neoplasms. Several factors are involved in diagnosing PM, including physical …
Molecular genetics of thrombotic myeloproliferative neoplasms: Implications in precision oncology
YC Chia, MJ Siti Asmaa, M Ramli, PY Woon, MF Johan… - Diagnostics, 2023 - mdpi.com
Classical BCR-ABL-negative myeloproliferative neoplasms (MPN) include polycythaemia
vera, essential thrombocythaemia, and primary myelofibrosis. Unlike monogenic disorders …
vera, essential thrombocythaemia, and primary myelofibrosis. Unlike monogenic disorders …
The impact of JAK2V617F mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis
Y Qin, X Wang, C Zhao, C Wang, Y Yang - International journal of …, 2015 - Springer
To assess the effect of JAK2V617F on different thrombotic risks in essential
thrombocythemia (ET) patients, we identified eligible studies from several databases …
thrombocythemia (ET) patients, we identified eligible studies from several databases …
Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis
G Cetin, T Ozkan, S Turgut, M Ali Cikrikcioglu… - Molecular biology …, 2014 - Springer
Essential thrombocythemia (ET) is an entity of classic Philadelphia chromosome-negative
myeloproliferative neoplasms (MPNs), characterized by thrombocytosis with megakaryocytic …
myeloproliferative neoplasms (MPNs), characterized by thrombocytosis with megakaryocytic …
TET2 Mutations in Ph‐Negative Myeloproliferative Neoplasms: Identification of Three Novel Mutations and Relationship with Clinical and Laboratory Findings
High‐throughput DNA sequence analysis was used to screen for TET2 mutations in
peripheral blood derived DNA from 97 patients with BCR‐ABL‐negative myeloproliferative …
peripheral blood derived DNA from 97 patients with BCR‐ABL‐negative myeloproliferative …
JAK2 V617F mutation status of 232 patients diagnosed with chronic myeloproliferative neoplasms
KB Payzin, K Savasoglu, I Alacacioglu… - … Myeloma and Leukemia, 2014 - Elsevier
Abstract Introduction/Background The aim of this study was to investigate the presence of
Janus kinase 2 (JAK2) V617F mutation in patients with break point cluster region-abelson …
Janus kinase 2 (JAK2) V617F mutation in patients with break point cluster region-abelson …
The role of Janus kinase 2 (JAK2) in myeloproliferative neoplasms: therapeutic implications
A Quintás-Cardama - Leukemia Research, 2013 - Elsevier
The acquired recurrent mutation, JAK2 V617F, is the most frequent mutation associated with
myeloproliferative neoplasms (MPNs). JAK2 signaling is critical in normal hematopoiesis …
myeloproliferative neoplasms (MPNs). JAK2 signaling is critical in normal hematopoiesis …
The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population
JH Ohyashiki, M Yoneta, H Hisatomi, T Iwabuchi… - BMC Medical …, 2012 - Springer
Background Polycythemia vera (PV), essential thrombocythemia (ET), and primary
myelofibrosis (PMF) are myeloproliferative neoplasms (MPNs) characterized in most cases …
myelofibrosis (PMF) are myeloproliferative neoplasms (MPNs) characterized in most cases …